Helix Receives FDA Emergency Use Authorization for the HelixⓇ COVID-19 NGS Test, One of the First Sequencing-Based COVID-19 Tests
- Monday, August 10, 2020, 7:04
- Finance
- Add a comment
SAN MATEO, Calif., Aug. 10, 2020 /PRNewswire/ — Helix, the leading population genomics company, announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the HelixⓇ COVID-19 NGS Test. The test is an amplicon-based…
About the Author
adminasapcorp has written 41558 stories on this site.